icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
60th Annual Meeting of the American Association for the Study of Liver Diseases
Boston, MA, Hynes Convention Center
October 30-November 3, 2009
Back grey_arrow_rt.gif
 
 
 
Once Daily Narlaprevir (SCH 900518) in Combination with Peginterferon alfa-2b/ Ribavirin for Treatment-Naive Patients with Genotype-1 Chronic Hepatitis C: Interim Results from the NEXT-1 Study
 
 
  Reported by Jules Levin
AASLD Nov 2 2009, Boston, MA
 
Vierling J, Poordad F, Lawitz E, Ghalib R, Lee W, Ravendhran N, Galati J, Bacon B, Flamm S, Balart L, Freilich B, Schiff E, Jacobson I, Kwo P, Gordon S, Sulkowski M, Boparai N, Chaudhri E, Brass C, Hughes E, and Albrecht J

image002.gif

image004.gif

image006.gif

image008.gif

image010.gif

image012.gif

image014.gif

image016.gif

image018.gif

image020.gif

image022.gif

image024.gif

image026.gif

image028.gif